Viewing StudyNCT03753685


Ignite Creation Date: 2025-12-18 @ 8:35 AM
Ignite Modification Date: 2025-12-18 @ 8:35 AM
Study NCT ID: NCT03753685
Status: None
Last Update Posted: 2025-07-23 00:00:00
First Post: 2018-11-22 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Sponsor:
Organization: